Tanaka, Nobuya
Azuma, Keiko
Aoki, Shuichiro
Kitamoto, Kohdai
Ueda, Kohei
Fujino, Ryosuke
Inoue, Tatsuya
Obata, Ryo http://orcid.org/0000-0002-1762-0797
Funding for this research was provided by:
The University of Tokyo
Article History
Received: 22 July 2023
Revised: 23 December 2023
Accepted: 20 January 2024
First Online: 31 January 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Tokyo Faculty of Medicine (#2217).
: Ryo Obata has received honoraria for speaking and consulting from Santen, Bayer, Novartis, Chugai, Senju, and Boehringer Ingelheim.